Track topics on Twitter Track topics that are important to you
IBM’s Clinical Trial Management System (CTMS) for Sites is designed to streamline the clinical trials management process and maximise operational efficiencies. Launched on 1 August, the system supports large hospitals and academic organisations as well as independent research organisations.
Formerly known as Merge Clinical Trial Management System for Investigators, CTMS for Sites is a platform used by those conducting research to organise, centralise and manage clinical research operations and finances across their institution. When implemented as part of the central research infrastructure at clinical research sites, it is said to reduce financial compliance risk, reduce the burden of duplicate data entry, increase performance transparency across organisations and enable efficient patient recruitment.
Using CTMS for Sites, research teams can:
For more information, visit the IBM catalogue.
Original Article: IBM launches CTMS to streamline research operationsNEXT ARTICLE
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...